Inventor
MARKOFF LEWIS
US9 patents
⚠️ This page may combine multiple inventors who share the name “MARKOFF LEWIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
5 patentsUS7517531B2Apr 14, 2009
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
US HEALTH17 citations91
US6685948B1Feb 3, 2004
Replication-defective dengue viruses that are replication-defective in mosquitoes for use as vaccines
US HEALTH26 citations87
US7851194B2Dec 14, 2010
West Nile viruses with mutations in the 3′ terminal stem and loop secondary structure for use as live virus vaccines
US HEALTH6 citations73
US11753627B2Sep 12, 2023
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
US HEALTH0 citations61
US10837003B2Nov 17, 2020
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
US HEALTH0 citations50
WHITEHEAD STEPHEN S
2 patentsUS8075903B2Dec 13, 2011
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4
WHITEHEAD STEPHEN S14 citations90
US9783787B2Oct 10, 2017
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
WHITEHEAD STEPHEN S5 citations82
THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES
2 patentsUSRE46641EDec 19, 2017
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES5 citations83
USRE46631EDec 12, 2017
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES7 citations83